News

Eli Lilly to acquire gene-editing biotech company Verve Therapeutics for $1.3 billion. Here's why
US Big Pharma firm Eli Lilly & Co. agreed to buy gene-editing biotech company Verve Therapeutics Inc. for $1.3 billion as the ...